This course comprising didactic lectures, videos, case studies, and hands-on simulation labs discusses neuromodulation (SNS and PTNS) and botulinum toxin therapy to treat refractory overactive bladder (OAB). Emphasis is placed on procedural techniques and the variables associated with maximizing improvement of symptoms in patients with OAB and urge urinary incontinence.
Continuing Education Instructions and Disclosure Information
Contact hours available until 9/23/21.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: There are no disclosures to declare.
Speakers Conflict of Interest Disclosure:
Michael Kennelly, MD, FACS
Consultant: Allergan, Astellas, Boston Scientific, ColoplastOther: Study Grant: Allergan, Amphoro, Axonics, Cook Myosi-Ipsen, Fempulse, Taris, EBT Medical, Uro1
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: After completing this educational activity, the learner will be able to identify the mechanism of action of botulinum toxin and sacral nerve stimulation/ neuromodulation therapy for treatment of OAB symptoms.